[
    [
        {
            "time": "",
            "orginal_text": "格隆汇港股聚焦(1.4)︱多家房企公布2020年销售业绩；圆通速递国际年度纯利预增逾六倍",
            "features": {
                "keywords": [
                    "房企",
                    "销售业绩",
                    "圆通速递国际",
                    "纯利预增"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "房地产",
                    "物流"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "格隆汇港股聚焦(1.4)︱多家房企公布2020年销售业绩；圆通速递国际年度纯利预增逾六倍",
            "scores": {
                "News_content": "格隆汇港股聚焦(1.4)︱多家房企公布2020年销售业绩；圆通速递国际年度纯利预增逾六倍",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "上海医药(601607.SH)：盐酸二甲双胍片及硝酸甘油片通过仿制药一致性评价",
            "features": {
                "keywords": [
                    "上海医药",
                    "盐酸二甲双胍片",
                    "硝酸甘油片",
                    "仿制药一致性评价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "上海医药(601607.SH)：盐酸二甲双胍片及硝酸甘油片通过仿制药一致性评价",
            "scores": {
                "News_content": "上海医药(601607.SH)：盐酸二甲双胍片及硝酸甘油片通过仿制药一致性评价",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "恒指收涨0.89% 禽畜肉类板块领涨",
            "features": {
                "keywords": [
                    "恒指",
                    "禽畜肉类",
                    "领涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "食品饮料"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "恒指收涨0.89% 禽畜肉类板块领涨",
            "scores": {
                "News_content": "恒指收涨0.89% 禽畜肉类板块领涨",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "上海医药子公司中药饮片不合规 被重庆药监局通报 食药监处罚",
            "features": {
                "keywords": [
                    "上海医药",
                    "中药饮片",
                    "不合规",
                    "食药监处罚"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "上海医药子公司中药饮片不合规 被重庆药监局通报 食药监处罚",
            "scores": {
                "News_content": "上海医药子公司中药饮片不合规 被重庆药监局通报 食药监处罚",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "上药生物医药产业基地正式开工，聚焦基因治疗等三大方向",
            "features": {
                "keywords": [
                    "上药生物",
                    "生物医药",
                    "基因治疗",
                    "产业基地"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "上药生物医药产业基地正式开工，聚焦基因治疗等三大方向",
            "scores": {
                "News_content": "上药生物医药产业基地正式开工，聚焦基因治疗等三大方向",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "投资未来，新晋世界500强80亿元落子张江，另有年产2亿剂疫苗基地在建",
            "features": {
                "keywords": [
                    "世界500强",
                    "张江",
                    "疫苗基地"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "投资未来，新晋世界500强80亿元落子张江，另有年产2亿剂疫苗基地在建",
            "scores": {
                "News_content": "投资未来，新晋世界500强80亿元落子张江，另有年产2亿剂疫苗基地在建",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]